Here's why the Creso Pharma (ASX:CPH) share price is storming 11% higher

The Creso Pharma Ltd (ASX:CPH) share price is storming higher on Monday after announcing its expansion into a new market…

| More on:
Investor happily looking at rising share price on laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price has been a strong performer on Monday morning.

At one stage today, the cannabis company's shares were up as much as 11% to 25 cents.

The Creso Pharma share price has since pulled back a touch but remains 4.5% higher at 23.5 cents.

Why is the Creso Pharma share price racing higher?

Investors have been buying Creso Pharma shares after it announced its expansion into the Pakistan market.

According to the release, the company has signed a comprehensive distribution agreement with leading nutritional supplements company, Route2 Pharm.

The agreement will see Route2 Pharm import, market, distribute, and sell the company's hemp derived therapeutic products exclusively into Pakistan and The Philippines. Route2 Pharm will also have non-exclusive rights to other potential target markets including Cambodia, Afghanistan, Azerbaijan, Bangladesh, Georgia, the Maldives, Myanmar, Tajikistan, Turkmenistan, Uzbekistan, and Vietnam.

The release explains that Route2 Pharma is a subsidiary of Route2Health. It has over thirty years of pharmaceutical sciences experience and produces and distributes world-class herbal remedies and dietary supplements. Route2Health is based in Pakistan and has United States Pharmacopeia (USP) GMP compliant manufacturing facilities and global partnerships.

As part of the agreement, to retain its exclusivity rights in Pakistan and The Philippines, Route2 Pharm must make minimum order quantities worth approximately $2.5 million a year.

Creso Pharma's Non-Executive Chairman, Adam Blumenthal, commented: "This Agreement has the potential to take Creso into markets with a combined population of over 750 million people. Our mission is to deliver access to affordable, high quality, broad spectrum, GMP products for the betterment of people's lives everywhere. We're delighted to conclude this important partnership, through which we hope to provide the opportunity for millions of people to have access to our innovative products."

This latest gain means the Creso Pharma share price is now up 31% since the start of the year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A diverse group of people form a circle at a park and raise their arms together.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors pulled back from the market's record highs this Thursday.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why DroneShield, EOS, Larvotto, and Life360 shares are racing higher today

These shares are having a strong session. But why?

Read more »

Green stock market graph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was one for the history books today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Boss Energy, DroneShield, Pilbara Minerals, and Polynovo shares are charging higher today

These shares are having a good time on hump day. But why?

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a nervous, but positive, Tuesday for ASX investors.

Read more »

two colleagues high five each other as they sit side by side at a long desk in front of their laptop computers in an office environment.
Share Gainers

Why Bapcor, Ramelius, Sandfire, and WIA Gold shares are rising today

These shares are having a better day than most on Tuesday. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors started the week off in a good mood today.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Bellevue Gold, Bubs, Clarity Pharmaceuticals, and Regal Partners shares are rising today

These shares are starting the week on a positive note.

Read more »